In a state steeped in advanced research that spawns biomedical companies by the dozen, Apricity LLC is preposterously low-tech,
given that its latest product is nothing more than a warm blanket.
When it comes to health care reform, Eli Lilly and Co. has its derriere exposed more than its drugmaker peers.
Rating doctors via online services helps consumers make better health care decisions.
As health care slowly shifts to operate more like retail stores, patients’ opinions of doctors have become commonplace on more than 30 physician-rating Web sites, including a subscription service run by Indianapolis-based Angie’s List.
Eli Lilly & Co. executives are making many trips to Washington to argue for 14 years of sales exclusivity for new drugs made
from cells.
The Indiana Chamber of Commerce has named Indianapolis-based health care research and testing firm AIT Laboratories its 2009
Small Business of the Year.
Catheter Research Inc. now is flying high—even in the midst of a bad economy.
Indianapolis-based medical-device startup NICO Corp. has raised $1.73 million from investors.
Indiana Medicaid officials want to take over management of all its patients’ prescription drugs because they say it could save the state as much as $40 million a year.
Patients are seeking help with their doctors, records and referrals as the health care system grows increasingly complex.
President Barack Obama’s economic stimulus bill provides a big opportunity for the Indianapolis-based Indiana Health Information Exchange to spread its expertise around the country.
Less than three years into its life, Indianapolis-based My Health Care Manager is going national.
Eli Lilly & Co. has filed lawsuits against seven generic drug companies in federal court in Indianapolis, asking a judge to
declare its Cymbalta patent valid and to tell the generic companies to back off.
As co-founder and head of sales and marketing, Brooke Billingsley has helped build Indianapolis-based Perception Strategies
Inc. — a health
care mystery shopping business co-founded by her husband, Kevin.
Retail developers always have been an audacious breed. They spend millions to build shopping centers, confident that tenants will flock to fill the slots they didn’t prelease. To charge ahead these days takes more than the usual dose of intestinal fortitude. Everyone is nervous — from shoppers to lenders to retailers, many of which have […]
Hoping to increase sales in China’s rapidly growing pharmaceutical market, Eli Lilly and Co. is charging ahead
with
plans to invest $100 million in venture capital in the region over the next several years.
Dr. Francis Price Jr. has brought hundreds of eye surgeons to Indianapolis to train them in how to use
a new cornea transplant technique that has swept the ophthalmology field—DSEK, which stands
for Descemet’s stripping endothelial keratoplasty.
The St. Francis hospital system and Anthem Blue Cross and Blue Shield of Indiana are haggling over insurance reimbursement
costs. The original demand of Sisters of St. Francis Health Services Inc. would have increased reimbursement amounts $80 million
over three years, Rick Rhodes, an Anthem regional vice president, wrote in an Oct. 30 letter to employers covered by Anthem.
The increase would mean $12 million more in out-of-pocket costs to Anthem customers. But St. Francis claims its request for
an increase only brings it in line with what other hospitals are getting.
Eli Lilly and Co. has written a $6.5 billion IOU to acquire the cancer drugs of ImClone Systems Inc. Cancer drugs are now
the best-selling class of drugs in the world and one of the fastest growing.
Eli Lilly and Co.’s unorthodox efforts to develop new treatments for Alzheimer’s disease–if successful–could usher in
a new approach to drug development. The Indianapolis-based pharmaceutical company announced that a New York
hedge fund, TPG-Axon Capital, will invest up to $325 million to help cover the exorbitant development costs
of two experimental compounds to treat Alzheimer’s disease.
